source
- Eli Lilly ends partnership with Foghorn Therapeutics, prompting 40% staff cut at biotechEli Lilly announced it is withdrawing from its collaboration with Foghorn Therapeutics on a synthetic lethality drug program. Following the pullback, Foghorn said it will cut roughly 40% of its wo…
- Regeneron antibody restores muscle loss in patients after stopping Wegovy, mid-stage data showRegeneron presented new mid-stage data at the European Association for the Study of Diabetes (EASD) meeting in Milan showing its investigational antibody can help patients with obesity recover musc…